Charles Piller

you know, I'm going to pass on this one. I just feel like it's a little outside my area of expertise. Because I'm just trying to think from a rational standpoint of how to get around this issue that the FDA- Yeah, there's already, I do know there are already exemptions that the agency has the ability to grant exemptions.

Companies have, I can't remember what the name of this expression is used for it, but they can give people drugs for, you know, cases where they can't afford the drug and there's a certain number of exemptions that they'll give for that, especially for rare diseases, but I don't know all the ins and outs of it.

Companies have, I can't remember what the name of this expression is used for it, but they can give people drugs for, you know, cases where they can't afford the drug and there's a certain number of exemptions that they'll give for that, especially for rare diseases, but I don't know all the ins and outs of it.

Companies have, I can't remember what the name of this expression is used for it, but they can give people drugs for, you know, cases where they can't afford the drug and there's a certain number of exemptions that they'll give for that, especially for rare diseases, but I don't know all the ins and outs of it.

When it comes to the FDA, we're talking about the medications of it all right now, but there's also the world of medical devices. And now that world is moving so rapidly, probably faster than ever before with exponential rise in AI. You have all the interesting stuff Elon Musk is up to. What do you think the future of the FDA is when it comes to devices and approvals of experimental devices?

When it comes to the FDA, we're talking about the medications of it all right now, but there's also the world of medical devices. And now that world is moving so rapidly, probably faster than ever before with exponential rise in AI. You have all the interesting stuff Elon Musk is up to. What do you think the future of the FDA is when it comes to devices and approvals of experimental devices?

When it comes to the FDA, we're talking about the medications of it all right now, but there's also the world of medical devices. And now that world is moving so rapidly, probably faster than ever before with exponential rise in AI. You have all the interesting stuff Elon Musk is up to. What do you think the future of the FDA is when it comes to devices and approvals of experimental devices?

I think it's a tremendously exciting time. I think there's a lot of potential there. And there's really, with AI, there's a lot of potential for new drug development as well. I think some of the claims being made are exaggerated because you still have to test drugs in people before they can be approved.

I think it's a tremendously exciting time. I think there's a lot of potential there. And there's really, with AI, there's a lot of potential for new drug development as well. I think some of the claims being made are exaggerated because you still have to test drugs in people before they can be approved.

I think it's a tremendously exciting time. I think there's a lot of potential there. And there's really, with AI, there's a lot of potential for new drug development as well. I think some of the claims being made are exaggerated because you still have to test drugs in people before they can be approved.

What's an exaggerated claim that you've heard?

What's an exaggerated claim that you've heard?

What's an exaggerated claim that you've heard?

Well, the idea that drug development is going to be sped up by many years for particular illnesses because of AI. I think there will be some advantages and new ideas will come out of it that are tremendously important. So I do subscribe to that. But look, the most difficult hurdle for drug is always human testing. And that still has to happen.

Well, the idea that drug development is going to be sped up by many years for particular illnesses because of AI. I think there will be some advantages and new ideas will come out of it that are tremendously important. So I do subscribe to that. But look, the most difficult hurdle for drug is always human testing. And that still has to happen.

Well, the idea that drug development is going to be sped up by many years for particular illnesses because of AI. I think there will be some advantages and new ideas will come out of it that are tremendously important. So I do subscribe to that. But look, the most difficult hurdle for drug is always human testing. And that still has to happen.

It has to happen in a safe and correct way to safeguard the public. So I would say that something that should be considered and this might not be very popular with the current change of administration in Washington, is that right now, company fees pay for FDA examination of their drugs or devices for approval.

It has to happen in a safe and correct way to safeguard the public. So I would say that something that should be considered and this might not be very popular with the current change of administration in Washington, is that right now, company fees pay for FDA examination of their drugs or devices for approval.

It has to happen in a safe and correct way to safeguard the public. So I would say that something that should be considered and this might not be very popular with the current change of administration in Washington, is that right now, company fees pay for FDA examination of their drugs or devices for approval.

And the logic of this is that the companies need the approval, and consequently, they should subsidize the agency to do this examination. But in my opinion, and I think in the opinion of a lot of people who have studied this, this creates an inherent conflict of interest for the agency.